Subscribe to our Newsletter
Dr. Sanchez-Bayona explores strategies for identifying node-positive, high-risk early breast cancer patients and tailoring therapy to improve outcomes. The session focuses on integrating Verzenio with endocrine therapy and leveraging clinical guidelines for optimal patient care.
